✨
AI Summary
- Andrew Hessel discusses rewriting genomes and using living systems.
- He is CEO of Humane Genomics Inc., developing cancer therapies.
- Hessel explores the potential of synthetic biology.
Guests on This Episode
AH
Andrew Hessel
1 podcast appearance